Brief: Bioretec Clarifies Its 2026-2028 Financial Target Regarding The Sales Margin
13/05/2026 12:38
May 13 (Reuters) - Bioretec Oy BRETEC.HE: BIORETEC CLARIFIES ITS 2026-2028 FINANCIAL TARGET REGARDING THE SALES MARGIN Source text: ID:nPre4fp6Qa Further company coverage: BRETEC.HE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million